Deborah A. Thomas
Impact in
- Hematology top 0.01%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Genetics top 0.01%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Genetics 222
- Chronic Lymphocytic Leukemia Research 172
- Myeloproliferative Neoplasms: Diagnosis and Treatment 44
- Hematology 204
- Chronic Myeloid Leukemia Treatments 118
- Acute Myeloid Leukemia Research 97
- Multiple Myeloma Research and Treatments 17
- Co-authors
- Hagop M. Kantarjian (251 shared papers)Jörge E. Cortes (251 shared papers)Susan O’Brien (214 shared papers)Francis J. Giles (117 shared papers)Stefan Faderl (171 shared papers)Guillermo Garcia‐Manero (160 shared papers)Michael J. Keating (75 shared papers)Srđan Verstovšek (107 shared papers)
- Journals
- Blood (195 papers)Cancer (56 papers)Journal of Clinical Oncology (46 papers)British Journal of Haematology (11 papers)Leukemia Research (8 papers)
- Partner nations
- United StatesUnited KingdomGermany
In The Last Decade
Deborah A. Thomas
442 papers receiving 22.8k citations
Deborah A. Thomas's Hit Papers
Peers
Comparison fields: 5 of 154
- Hematology 11.1k
- Genetics 9.3k
- Pathology and Forensic Medicine 4.6k
- Public Health, Environmental and Occupational Health 5.2k
- Oncology 4.2k
Countries citing papers authored by Deborah A. Thomas
This map shows the geographic impact of Deborah A. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah A. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah A. Thomas more than expected).
Fields of papers citing papers by Deborah A. Thomas
This network shows the impact of papers produced by Deborah A. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah A. Thomas. The network helps show where Deborah A. Thomas may publish in the future.
Co-authors
The 25 scholars most cited alongside Deborah A. Thomas, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 451 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Lenalidomide in the Myelodysplastic Syndrome with Chromosome 5q Deletion Hit paper breakdown → | 2006 | 900 |
| 2 | Safety and Efficacy of INCB018424, a JAK1 and JAK2 Inhibitor, in Myelofibrosis Hit paper breakdown → | 2010 | 856 |
| 3 | Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia Hit paper breakdown → | 2005 | 705 |
| 4 | Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignancies Hit paper breakdown → | 2003 | 632 |
| 5 | Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes Hit paper breakdown → | 2000 | 561 |
| 6 | Long-term results of the fludarabine, cyclophosphamide, and rituximab regimen as initial therapy of chronic lymphocytic leukemia Hit paper breakdown → | 2008 | 509 |
| 7 | 2001 | 468 | |
| 8 | 2004 | 461 | |
| 9 | 2003 | 401 | |
| 10 | 2003 | 401 | |
| 11 | 2005 | 401 | |
| 12 | 2006 | 371 | |
| 13 | 2007 | 311 | |
| 14 | Inotuzumab ozogamicin, an anti-CD22–calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study Hit paper breakdown → | 2012 | 310 |
| 15 | 2010 | 307 | |
| 16 | 2003 | 298 | |
| 17 | 2010 | 282 | |
| 18 | 2007 | 253 | |
| 19 | 2006 | 239 | |
| 20 | 2013 | 232 |
About Deborah A. Thomas
Deborah A. Thomas is a scholar working on Genetics, Hematology, Public Health, Environmental and Occupational Health, Molecular Biology and Pathology and Forensic Medicine, having authored 451 papers that have together received 23.3k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (182 papers), Chronic Lymphocytic Leukemia Research (172 papers), Chronic Myeloid Leukemia Treatments (118 papers), Acute Myeloid Leukemia Research (97 papers), Lymphoma Diagnosis and Treatment (71 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (44 papers), Multiple Myeloma Research and Treatments (17 papers) and Childhood Cancer Survivors' Quality of Life (16 papers). The work is most often cited by research in Hematology (11.1k citations), Genetics (9.3k citations), Pathology and Forensic Medicine (4.6k citations), Public Health, Environmental and Occupational Health (5.2k citations) and Oncology (4.2k citations). Deborah A. Thomas has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Hagop M. Kantarjian, Jörge E. Cortes, Susan O’Brien, Francis J. Giles, Stefan Faderl, Guillermo Garcia‐Manero, Michael J. Keating, Srđan Verstovšek, Maher Albitar and Charles Koller. Their work appears in journals such as Blood, Cancer, Journal of Clinical Oncology, British Journal of Haematology and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.